Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Qinyan Zou"'
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 21, Iss , Pp 37-50 (2020)
Human amniotic mesenchymal stem cells (hAMSCs) were previously shown to effectively rescue ovarian function in a premature ovarian insufficiency (POI) mouse model. The therapeutic mechanism of hAMSC-derived exosomes (hAMSC-Exos) is not fully understo
Externí odkaz:
https://doaj.org/article/b34fb905ad06411599f7037d7aee2488
Autor:
Shunyu Hou, Chenyue Ding, Han Shen, Chunfeng Qian, Qinyan Zou, Jiafeng Lu, Boxian Huang, Jichun Tan, Hong Li
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-13 (2020)
Abstract Background Human amniotic epithelial cell (hAEC) transplantation holds great promise in treating premature ovarian insufficiency (POI). However, some deficient biological characteristics of hAECs restrict their application. Methods Vitamin C
Externí odkaz:
https://doaj.org/article/3ddb42002e684e4abd8c430313187f06
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-12 (2019)
Abstract Background With the development of regenerative medicine and tissue engineering technology, almost all stem cell therapy is efficacious for the treatment of premature ovarian failure (POF) or premature ovarian insufficiency (POI) animal mode
Externí odkaz:
https://doaj.org/article/4b440b1626ea4b4c83cd11bdb31aac6f
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 9, Iss 2, Pp n/a-n/a (2021)
Abstract Purpose This study is intended to investigate the candidate pathogenic gene in a patient with primary infertility but without the defect in routine semen parameters from a consanguineous family and explore the potential impacts of mutations
Externí odkaz:
https://doaj.org/article/6559bd3850fd42f5a6d438b5479c8b22
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Many studies have shown that mesenchymal stem cells have the ability to restore function in models of premature ovarian insufficiency disease, but few studies have used stem cells in the treatment of ovarian physiologic aging (OPA). This experimental
Externí odkaz:
https://doaj.org/article/294117682a2f49f088892cd3310f9f4b
Publikováno v:
Stem Cell Research & Therapy, Vol 9, Iss 1, Pp 1-12 (2018)
Abstract Background Although many reports show that various kinds of stem cells have the ability to recover the function of premature ovarian insufficiency (POI), few studies are associated with the mechanism of stem cell treatment of POI. We designe
Externí odkaz:
https://doaj.org/article/b091e91ae5294af6b4600487440dc0ae
Autor:
Chenyue Ding, Qinyan Zou, Fuxin Wang, Huihua Wu, Rulei Chen, Jinghuan Lv, Mingfa Ling, Jian Sun, Wei Wang, Hong Li, Boxian Huang
Publikováno v:
Stem Cell Research & Therapy, Vol 9, Iss 1, Pp 1-11 (2018)
Abstract Background Although many reports show that various kinds of stem cells have the ability to recover function in premature ovarian aging, few studies have looked at stem cell treatment of natural ovarian aging (NOA). We designed this experimen
Externí odkaz:
https://doaj.org/article/088a201ae4b240e89243a38a61c0ee7e
Publikováno v:
Cellular Physiology and Biochemistry, Vol 45, Iss 4, Pp 1316-1332 (2018)
Background/Aims: Human adipose-derived stem cells (hADSCs) are a potential therapeutic option for clinical applications because of their ability to produce cytokines and their capacity for trilineage differentiation. To date, few researchers have inv
Externí odkaz:
https://doaj.org/article/d2ea18b6b0fd4022a1ed7b086b932cbd
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Cyclophosphamide (CTX) is one of the most frequently used alkylating anticancer drugs. CTX is associated with reproductive failure and premature ovarian insufficiency (POI) or premature ovarian aging. Much less is known about the mechanism by which C
Externí odkaz:
https://doaj.org/article/297e4c99905f41c29b114657c7438deb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.